A phase I/IIa trial of prostate specific membrane antigen (PSMA) positron emission tomography (PET) imaging with 89Zr-Df-IAB2M in metastatic prostate cancer (PCa).
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Michael J. Morris, Danny Francisco Martinez, Jeremy C. Durack, Susan F. Slovin, Daniel Costin Danila, Joseph A. O' Donoghue, Nicole Andrea Parada, Serge K. Lyashchenko, Jorge A. Carrasquillo, Shutian Ruan, Jason Stuart Lewis, Jennifer Keppler, Anna M. Wu, Victor E. Reuter, Wolfgang Weber, Howard I. Scher, Steven M. Larson, Neeta Pandit-Taskar
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589840989